
2022 Resident Education Program
ABOUT THE RESIDENT EDUCATION PROGAM
The aim of this program is to provide early stage adult and pediatric neurology residents with a foundation in headache medicine education led by experienced faculty in neurologic education and headache medicine.
We hope that this program will inspire a greater number of junior neurology trainees to consider pursuing careers in headache medicine.
PROGRAM DETAILS
This fall, the American Headache Society’s Resident Education Program will be held in-person starting the evening of Friday, September 30 through the morning of Sunday, October 2, 2022 at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, CA.
Faculty and residents will engage throughout the meeting in an interactive format that features lectures, small group sessions and workshops, and a friendly competition, as well as informally at combined faculty-resident meals and breaks.
The Resident Education Program will:
- Provide early stage adult and pediatric neurology residents with a foundation in headache medicine education.
- Promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders.
- Introduce residents to experienced faculty in neurologic education and headache medicine.
- Inspire a greater number of neurology residents to pursue careers in headache medicine.
ACCEPTED APPLICANTS
Applicants who are accepted into the program will receive will receive a stipend up to $1,500 for reimbursement of eligible travel expenses and a complimentary one-year Trainee membership to the American Headache Society, or extension of their existing AHS Trainee membership.
HEALTH AND SAFETY
AHS is committed to protecting your health and safety during the Resident Education Program. All attendees and faculty are required to be vaccinated against the COVID-19 virus (at least 14 days after receiving the second Pfizer or Moderna dose or the Johnson and Johnson dose) prior to arriving to meeting. Participants will need to provide proof of vaccination (a vaccine card or picture) during badge pickup. Masks are required for all participants while inside the meeting space, except during eating or drinking.

2022 Resident Education Program
Program Committee
![]() Matthew S. Robbins, MD, FAHS, Chair |
![]() Deborah I. Friedman, MD, MPH, FAHS |
![]() Amy Gelfand, MD, MAS, FAHS |
![]() Peter J. Goadsby, MD, PhD, FAHS |
![]() Melissa Rayhill, MD, FAHS |
![]() Noah Rosen, MD, FAHS |
![]() Niushen Zhang, MD, FAHS |
Program Faculty
Check back soon!

2022 Resident Education Program
Preliminary Program Agenda
September 30 – October 2, 2022 (all times PST)
Friday, September 30, 2022 | |
3:00PM – 6:00PM | Check-in |
7:00PM – 8:30PM | Faculty and Resident Reception |
Saturday, October 1, 2022 | |
7:00AM – 8:00AM | Breakfast |
8:00AM – 8:10AM | Introduction |
8:10AM – 12:30PM | SESSION 1: BASICS OF HEADACHE IN ADULTS AND CHILDREN |
8:10AM – 8:40AM | Headache Diagnosis |
8:40AM – 9:10AM | Headache Epidemiology and Comorbidity |
9:10AM – 9:40AM | Headache Pathophysiology |
9:40AM – 10:00AM | Faculty Q&A |
10:00AM – 10:20AM | Coffee break and group photo |
10:20AM – 10:50AM | Migraine Treatment |
10:50AM – 11:20AM | Headache in Children and Adolescents |
11:20AM – 11:50AM | Trigeminal Autonomic Cephalalgias |
11:50AM – 12:20PM | Other Headache and Facial Pain Disorders |
12:20PM – 12:40PM | Faculty Q&A |
12:40PM – 1:40PM | Lunch |
1:40PM – 4:00PM | SESSION 2: HEADACHE ROUNDS 4 rotating small group workshops – each 30 minutes / 5 minute break to rotate rooms
|
4:00PM – 4:30PM | Break |
4:30PM – 6:00PM | SESSION 3: HEADACHE CHALLENGE East versus West Competition: Images in Headache |
6:00PM – 7:00PM | Break |
7:00PM – 9:00PM | Dinner with All Faculty: Spotlight on Headache Careers |
Sunday, October 2, 2022 | |
7:00AM – 8:00AM | Breakfast |
8:00AM – 11:00AM | SESSION 4: ADVANCED HEADACHE THERAPIES |
8:00AM – 8:25AM | Novel Pharmaceutical Therapies |
8:25AM – 8:50AM | Neuromodulation |
8:50AM – 9:15AM | Behavioral Therapies |
9:15AM – 9:40AM | Headache Procedures |
9:40AM – 9:50AM | Faculty Q&A |
9:50AM – 9:55AM | Concluding Remarks |
9:55AM – 11:00AM | Procedure Workshop |
11:00AM | Adjourn |

2022 Resident Education Program
Application Criteria:
- Submit the online application form with the following supporting documents:
- Completion of brief statement of interest (100-200 words)
- CV
- Letter of support from Program Director
- Each program director may nominate only one early stage resident from their program (PGY1 or PGY2 for adult neurology, PGY1, PGY2, or PGY3 for child neurology, but if no such candidate is available a PGY3 adult neurology or PGY4 child neurology resident would be considered).
- Applicant must be a resident in a US adult or pediatric neurology training program. We will also consider applications from trainees in other residency programs, including but not limited to internal medicine, family medicine, pediatrics, physiatry, obstetrics and gynecology, and orofacial pain. International applications are not eligible at this time.
Accepted participants will receive the following:
- Reimbursement up to $1,500 for eligible travel expenses including:
- Roundtrip coach/economy class travel
- Ground transportation to/from airport and conference center (car rental and gas not covered)
- Two nights’ accommodation at the conference hotel
- Meals, which are included in the meeting, from Friday night through Sunday morning.
- Complimentary one-year trainee membership to the American Headache Society or extension of an existing AHS Trainee membership

2022 Resident Education Program
The American Headache Society gratefully acknowledges the support of the 2022 Resident Education Program from our industry supporters:
GOLD
![]() We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company. |
![]() For the past two decades, Collegium Pharmaceutical has been focused on developing and commercializing new medicines for pain management. Today, our mission is to build a leading, diversified specialty pharmaceutical company that reflects our Core Values and our commitment to improving the lives of people living with serious medical conditions. |